我国肝癌研究的现状与前景

[1] The global burden of liver disease: The major impact of China[J] . Fu‐Sheng Wang,Jian‐Gao Fan,Zheng Zhang,Bin Gao,Hong‐Yang Wang.Hepatology . 2014 (6)

[2] Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis[J] . Xiaobo Jia,Jiao Liu,Yingtang Gao,Yong Huang,Zhi Du.Archives of Medical Research . 2014 (7)

[3] Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes [J]. CELL STEM CELL, 2014, 14 (03) : 370 - 384

[4] Long noncoding RNAs: Novel insights into hepatocelluar carcinoma[J] . Yong He,Xiao-Ming Meng,Cheng Huang,Bao-Ming Wu,Lei Zhang,Xiong-Wen Lv,Jun Li.Cancer Letters . 2014 (1)

[5] Association of Nucleos（t）ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study[J] . Chun-Ying Wu,Jaw-Town Lin,Hsiu J. Ho,Chien-Wei Su,Teng-Yu Lee,Shen-Yung Wang,Chuhui Wu,Jaw-Ching Wu.Gastroenterology . 2014

[6] Autophagy Suppresses Tumorigenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma Through Degradation of MicroRNA-224 [J]. HEPATOLOGY, 2014, 59 (02) : 505 - 517

[7] Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway [J]. CELLULAR SIGNALLING, 2013, 25 (12) : 2805 - 2811

[8] Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma[J] . Jin Hou,Ye Zhou,Yuanyuan Zheng,Jia Fan,Weiping Zhou,Irene O.L. Ng,Huichuan Sun,Lunxiu Qin,Shuangjian Qiu,Joyce M.F. Lee,Chung-Mau Lo,Kwan Man,Yuan Yang,Yun Yang,Yingyun Yang,Qian Zhang,Xuhui Zhu,Nan Li,Zhengxin Wang,Guoshan Ding,Shi-Mei Zhuang,Limin Zheng,Xiaoling Luo,Yuan Xie,Anmin Liang,Zhugang Wang,Ming Zhang,Qiang Xia,Tingbo Liang,Yizhi Yu,Xuetao Cao.Cancer Cell . 2013

[9] Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics [J]. CANCER RESEARCH, 2013, 73 (16) : 4992 - 5002

[10] 1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit[J] . Wei Zhao,Limin Wang,Haibo Han,Kemin Jin,Na Lin,Ting Guo,Yangde Chen,Heping Cheng,Fengmin Lu,Weigang Fang,Yu Wang,Baocai Xing,Zhiqian Zhang.Cancer Cell . 2013 (4)

[1] The global burden of liver disease: The major impact of China[J] . Fu‐Sheng Wang,Jian‐Gao Fan,Zheng Zhang,Bin Gao,Hong‐Yang Wang.Hepatology . 2014 (6)

[2] Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis[J] . Xiaobo Jia,Jiao Liu,Yingtang Gao,Yong Huang,Zhi Du.Archives of Medical Research . 2014 (7)

[3] Direct Reprogramming of Human Fibroblasts to Functional and Expandable Hepatocytes [J]. CELL STEM CELL, 2014, 14 (03) : 370 - 384

[4] Long noncoding RNAs: Novel insights into hepatocelluar carcinoma[J] . Yong He,Xiao-Ming Meng,Cheng Huang,Bao-Ming Wu,Lei Zhang,Xiong-Wen Lv,Jun Li.Cancer Letters . 2014 (1)

[5] Association of Nucleos（t）ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study[J] . Chun-Ying Wu,Jaw-Town Lin,Hsiu J. Ho,Chien-Wei Su,Teng-Yu Lee,Shen-Yung Wang,Chuhui Wu,Jaw-Ching Wu.Gastroenterology . 2014

[6] Autophagy Suppresses Tumorigenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma Through Degradation of MicroRNA-224 [J]. HEPATOLOGY, 2014, 59 (02) : 505 - 517

[7] Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway [J]. CELLULAR SIGNALLING, 2013, 25 (12) : 2805 - 2811

[8] Hepatic RIG-I Predicts Survival and Interferon-α Therapeutic Response in Hepatocellular Carcinoma[J] . Jin Hou,Ye Zhou,Yuanyuan Zheng,Jia Fan,Weiping Zhou,Irene O.L. Ng,Huichuan Sun,Lunxiu Qin,Shuangjian Qiu,Joyce M.F. Lee,Chung-Mau Lo,Kwan Man,Yuan Yang,Yun Yang,Yingyun Yang,Qian Zhang,Xuhui Zhu,Nan Li,Zhengxin Wang,Guoshan Ding,Shi-Mei Zhuang,Limin Zheng,Xiaoling Luo,Yuan Xie,Anmin Liang,Zhugang Wang,Ming Zhang,Qiang Xia,Tingbo Liang,Yizhi Yu,Xuetao Cao.Cancer Cell . 2013

[9] Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics [J]. CANCER RESEARCH, 2013, 73 (16) : 4992 - 5002

[10] 1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit[J] . Wei Zhao,Limin Wang,Haibo Han,Kemin Jin,Na Lin,Ting Guo,Yangde Chen,Heping Cheng,Fengmin Lu,Weigang Fang,Yu Wang,Baocai Xing,Zhiqian Zhang.Cancer Cell . 2013 (4)